Abstract
Spinal muscular atrophy is a progressive and severe neuromuscular disorder and represents one of the causes of early disability and infant mortality. When SMA is suspected in a child, prompt diagnosis and timely initiation of treatment are essential, as subsequent health-related quality of life depends directly on early diagnosis and timely therapeutic intervention. Currently, several disease-modifying therapies have been developed that can influence the progression of the disease and improve the patient’s health-related quality of life. During pathogenetic treatment, changes in patients’ motor function can be observed. The most reliable way to assess this motor function dynamics is through standardized motor scales.

This publication has 12 references indexed in Scilit: